ALPK3 Antibody (monoclonal) (M01)
Mouse monoclonal antibody raised against a partial recombinant ALPK3.
|Application ||WB, IHC, IF|
|Calculated MW||201272 Da|
|Other Names||Alpha-protein kinase 3, 2711-, Muscle alpha-protein kinase, ALPK3, KIAA1330, MAK|
|Target/Specificity||ALPK3 (NP_065829, 1811 a.a. ~ 1906 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.|
|Format||Clear, colorless solution in phosphate buffered saline, pH 7.2 .|
|Storage||Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.|
|Precautions||ALPK3 Antibody (monoclonal) (M01) is for research use only and not for use in diagnostic or therapeutic procedures.|
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
email@example.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Complete sequencing and characterization of 21,243 full-length human cDNAs. Ota T, et al. Nat Genet, 2004 Jan. PMID 14702039.Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Strausberg RL, et al. Proc Natl Acad Sci U S A, 2002 Dec 24. PMID 12477932.A novel myocyte-specific gene Midori promotes the differentiation of P19CL6 cells into cardiomyocytes. Hosoda T, et al. J Biol Chem, 2001 Sep 21. PMID 11418590.Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro. Nagase T, et al. DNA Res, 2000 Feb 28. PMID 10718198.Alpha-kinases: a new class of protein kinases with a novel catalytic domain. Ryazanov AG, et al. Curr Biol, 1999 Jan 28. PMID 10021370.
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at firstname.lastname@example.org.